(VIANEWS) – Shares of TherapeuticsMD (NASDAQ Composite: TXMD) rose 8.62% to $0.83 at 11:01 EST on Monday, following the last session’s upward trend. NASDAQ Composite is jumping 1.03% to $14,865.94, after two consecutive sessions in a row of gains. This seems, so far, an all-around up trend trading session today.
TherapeuticsMD’s last close was $0.76, 72.36% under its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 1878709 which is 66.04% below its average volume of 5533115.
The company’s growth estimates for the present quarter and the next is 42.1% and 16.7%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current volatility was a negative 0.25%, a negative 0.81%, and a positive 3.47%, respectively.
TherapeuticsMD’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.68% (last week), 3.11% (last month), and 3.47% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.83 at 11:01 EST, way under its 52-week high of $2.75 and way above its 52-week low of $0.72.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $1.02 and way under its 200-day moving average of $1.29.
More news about TherapeuticsMD (TXMD).